BriaCell Therapeutics Corp. (BCTXL) › Capital ExpendituresBriaCell Therapeutics Corp. (BCTXL) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.Fiscal YearCapital ExpendituresChange YoY2024$456.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share